Mycophenolate Use in Females of Reproductive Potential: A Review of the Pharmacist's Role in Mycophenolate REMS
Tracking # 20-1314924
Free
Course overview
The goal of this educational activity is to educate pharmacists in all practice settings nationwide on the mechanism and uses of mycophenolate, the risks associated with using the drug in females of reproductive potential, and the importance of adherence to the Mycophenolate REMS program to improve safe use of the drug.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Pharmacy
Pharmacist
Disclosure statements
Dr. Enderby has no relevant affiliations or financial relationships with a commercial interest to disclose.
Dr. Chandran has disclosed that she has received honoraria for non-CME related activities from Eurofins Viracor.
The clinical reviewer, Lisa Holle, PharmD, BCOP, FHOPA, has disclosed that she has no relevant affiliations or financial relationships with a commercial interest to disclose.
The medical writer, Thomas Cook, RPh, PhD has no actual or potential conflicts of interest in relation to this program.
Susanne Kwas, MSHF, BSN, RN, Robin Soboti, RPh, and Susan R. Grady, MSN, RN as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.
All relevant financial relationships have been mitigated.